China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.7500
0.00 (0.00%)
At close: Feb 13, 2026
HKG:1011 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 4.63 | 9.62 | 1.52 | 5.93 | 9.44 | 7.69 |
Cash & Short-Term Investments | 4.63 | 9.62 | 1.52 | 5.93 | 9.44 | 7.69 |
Cash Growth | -48.03% | 533.09% | -74.37% | -37.19% | 22.73% | -89.46% |
Accounts Receivable | 23.14 | - | 10.05 | 33.67 | 12.45 | 25.96 |
Other Receivables | - | 0.08 | 0.55 | 20.78 | 21.52 | 372.54 |
Receivables | 23.14 | 0.08 | 10.6 | 54.45 | 33.98 | 398.51 |
Inventory | 0.45 | 0.17 | - | 10.32 | 32.01 | 27.29 |
Prepaid Expenses | - | 5.02 | 0.11 | - | - | - |
Other Current Assets | - | 1.29 | 0.05 | 2.74 | 192.28 | 143.47 |
Total Current Assets | 28.22 | 16.19 | 12.28 | 73.43 | 267.7 | 576.96 |
Property, Plant & Equipment | 1.08 | 0.54 | 0.94 | 379.72 | 222.37 | 419.83 |
Long-Term Investments | 315.06 | 317.28 | 313.55 | 277.58 | 278.46 | 17.44 |
Other Intangible Assets | - | - | 0.2 | 274.98 | 186.83 | 280.84 |
Other Long-Term Assets | 0.05 | 0.07 | 2.16 | - | - | - |
Total Assets | 344.41 | 334.08 | 329.12 | 1,006 | 955.36 | 1,295 |
Accounts Payable | 6.96 | 2.22 | 5 | 8.48 | 44.63 | 46.7 |
Accrued Expenses | 126.74 | 143.99 | 118.64 | 170.56 | 100.1 | 102.28 |
Short-Term Debt | 266.6 | 313.81 | 286.09 | 348.07 | 140.45 | - |
Current Portion of Long-Term Debt | 49.06 | 53.69 | 54.62 | 476.97 | 476.38 | 796.25 |
Current Portion of Leases | 0.69 | 0.34 | 0.63 | 0.95 | 1.61 | 3.16 |
Current Income Taxes Payable | - | - | 0.12 | 25.05 | 13.98 | 12.2 |
Current Unearned Revenue | - | - | - | 4.8 | 6.1 | 5.81 |
Other Current Liabilities | 170.87 | 211.02 | 199.98 | 134.82 | 112.73 | 190.05 |
Total Current Liabilities | 620.91 | 725.07 | 665.09 | 1,170 | 895.97 | 1,156 |
Long-Term Debt | - | 7.99 | 3.22 | - | 213.29 | 45.64 |
Long-Term Leases | 0.38 | 0.13 | 0.38 | 0.46 | 0.39 | 6.42 |
Long-Term Deferred Tax Liabilities | - | - | - | 77.22 | 57.08 | 63.69 |
Other Long-Term Liabilities | - | - | - | - | - | 0.47 |
Total Liabilities | 621.29 | 733.18 | 668.69 | 1,247 | 1,167 | 1,273 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 1,932 | 1,806 | 1,806 | 1,759 | 1,759 | 1,759 |
Retained Earnings | -2,566 | -2,549 | -2,498 | -2,639 | -2,537 | -2,371 |
Comprehensive Income & Other | 357.53 | 343.89 | 351.98 | 638.24 | 566.86 | 628.24 |
Total Common Equity | -276.88 | -399.11 | -339.57 | -241.66 | -211.38 | 16.28 |
Minority Interest | - | - | - | - | - | 6.14 |
Shareholders' Equity | -276.88 | -399.11 | -339.57 | -241.66 | -211.38 | 22.42 |
Total Liabilities & Equity | 344.41 | 334.08 | 329.12 | 1,006 | 955.36 | 1,295 |
Total Debt | 316.72 | 375.95 | 344.94 | 826.45 | 832.11 | 851.46 |
Net Cash (Debt) | -312.09 | -366.33 | -343.42 | -820.52 | -822.67 | -843.76 |
Net Cash Per Share | -0.76 | -1.39 | -1.44 | -4.32 | -4.35 | -4.47 |
Filing Date Shares Outstanding | 674.25 | 264.09 | 264.09 | 190.46 | 190.46 | 190.46 |
Total Common Shares Outstanding | 674.25 | 264.09 | 264.09 | 190.46 | 190.46 | 190.46 |
Working Capital | -592.69 | -708.88 | -652.81 | -1,096 | -628.27 | -579.48 |
Book Value Per Share | -0.41 | -1.51 | -1.29 | -1.27 | -1.11 | 0.09 |
Tangible Book Value | -276.88 | -399.11 | -339.76 | -516.64 | -398.21 | -264.57 |
Tangible Book Value Per Share | -0.41 | -1.51 | -1.29 | -2.71 | -2.09 | -1.39 |
Buildings | - | - | - | 363.03 | 207.26 | 378.9 |
Machinery | - | 0.02 | 0.16 | 87.27 | 38.16 | 89.01 |
Construction In Progress | - | - | - | 5.83 | 1.5 | 1.85 |
Leasehold Improvements | - | - | - | 9.73 | 9.25 | 10.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.